Trial intelligence / Profile preview

Ciprofol Outcomes in Elderly Abdominal Surgery (CP-EASO)

ChiCTR2600128494Phase 4Not yet recruiting

Sponsor
Zhongda Hospital, Southeast University
Start
Jul 2026
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol (2 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: Postoperative complications (in-hospital organ dysfunction). Planned start Jul 2026; status: not yet recruiting.

02

Drugs

ciprofol

Beyond the preview

Go deeper on ChiCTR2600128494.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600128494.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call